| |
| |
|
| Insider
Information: |
Ellison Mark Jason Heath |
| Relationship: |
Chief Development Offi... |
| City: |
Santa Monica |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Opiant Pharmaceuticals Inc |
OPNT |
Chief Development Offi... |
2023-03-02 |
0 |
2023-03-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
12 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| OPNT |
Opiant Pharmaceuticals In... |
Chief Development Officer |
• – – |
2023-03-02 |
4 |
D |
$20.00 |
$415,020 |
D/D |
(20,751) |
0 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Development Officer |
• – – |
2023-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
2,000 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Development Officer |
• – – |
2023-03-02 |
4 |
D |
$20.00 |
$193,600 |
I/I |
(9,680) |
0 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Development Officer |
• – – |
2023-01-27 |
4 |
S |
$20.26 |
$12,359 |
D/D |
(610) |
18,751 |
0 |
% |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Development Officer |
• – – |
2023-01-09 |
4 |
S |
$20.20 |
$9,474 |
D/D |
(469) |
19,361 |
0 |
% |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Development Officer |
• – – |
2023-01-05 |
4 |
S |
$20.20 |
$36,481 |
D/D |
(1,806) |
19,830 |
0 |
% |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Development Officer |
• – – |
2022-06-27 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
21,636 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Development Officer |
• – – |
2022-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
12,000 |
19,636 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Development Officer |
• – – |
2021-01-26 |
4 |
A |
$0.00 |
$0 |
D/D |
7,636 |
7,636 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
UK Managing Director |
– – – |
2020-01-07 |
4 |
A |
$0.00 |
$0 |
I/I |
4,150 |
9,680 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
UK Managing Director |
– – – |
2019-07-29 |
4 |
D |
$12.26 |
$300,002 |
I/I |
(24,470) |
5,530 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
UK Managing Director |
– – – |
2019-07-29 |
4 |
OE |
$10.00 |
$300,000 |
I/I |
30,000 |
30,000 |
0 |
- |
|
12 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
